A. D. Beadell Investment Counsel Inc. increased its stake in Stericycle Inc (NASDAQ:SRCL) by 8.2% during the first quarter, Holdings Channel reports. The institutional investor owned 12,225 shares of the business services provider’s stock after buying an additional 930 shares during the period. A. D. Beadell Investment Counsel Inc.’s holdings in Stericycle were worth $1,013,000 as of its most recent SEC filing.
A number of other hedge funds also recently bought and sold shares of SRCL. PGGM Investments raised its stake in shares of Stericycle by 4.7% in the third quarter. PGGM Investments now owns 72,405 shares of the business services provider’s stock valued at $5,803,000 after buying an additional 3,245 shares during the period. HL Financial Services LLC acquired a new stake in shares of Stericycle during the third quarter valued at $335,000. State of Alaska Department of Revenue raised its stake in shares of Stericycle by 6.1% in the third quarter. State of Alaska Department of Revenue now owns 6,168 shares of the business services provider’s stock valued at $494,000 after buying an additional 356 shares during the period. Factory Mutual Insurance Co. raised its stake in shares of Stericycle by 50.0% in the third quarter. Factory Mutual Insurance Co. now owns 108,000 shares of the business services provider’s stock valued at $8,655,000 after buying an additional 36,000 shares during the period. Finally, CGOV Asset Management acquired a new stake in shares of Stericycle during the third quarter valued at $8,365,000. Institutional investors own 94.49% of the company’s stock.
Shares of Stericycle Inc (NASDAQ:SRCL) traded up 0.52% during trading on Friday, hitting $85.56. 727,965 shares of the company’s stock were exchanged. Stericycle Inc has a 1-year low of $71.52 and a 1-year high of $125.04. The stock’s 50-day moving average price is $82.17 and its 200-day moving average price is $78.34. The stock has a market cap of $7.29 billion, a PE ratio of 41.13 and a beta of 0.08.
Stericycle (NASDAQ:SRCL) last released its quarterly earnings results on Wednesday, February 15th. The business services provider reported $1.00 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.93 by $0.07. Stericycle had a net margin of 7.52% and a return on equity of 15.33%. The firm earned $906.40 million during the quarter, compared to analyst estimates of $902.62 million. During the same quarter last year, the business earned $1.11 EPS. On average, equities analysts expect that Stericycle Inc will post $4.62 earnings per share for the current fiscal year.
COPYRIGHT VIOLATION NOTICE: “Stericycle Inc (SRCL) Shares Bought by A. D. Beadell Investment Counsel Inc.” was originally published by BBNS and is the sole property of of BBNS. If you are reading this story on another website, it was illegally stolen and reposted in violation of United States and international copyright law. The correct version of this story can be accessed at https://baseballnewssource.com/markets/stericycle-inc-srcl-shares-bought-by-a-d-beadell-investment-counsel-inc/638199.html.
Several brokerages have recently weighed in on SRCL. Barclays PLC began coverage on shares of Stericycle in a research report on Thursday, April 13th. They set an “overweight” rating and a $100.00 target price on the stock. Royal Bank of Canada set a $74.00 target price on shares of Stericycle and gave the company a “sell” rating in a research report on Saturday, January 21st. Raymond James Financial, Inc. reiterated a “market perform” rating on shares of Stericycle in a research report on Monday, February 20th. Barrington Research lifted their target price on shares of Stericycle from $84.00 to $93.00 and gave the company an “outperform” rating in a research report on Wednesday, February 22nd. Finally, Zacks Investment Research lowered shares of Stericycle from a “hold” rating to a “sell” rating in a research report on Wednesday, February 1st. Two research analysts have rated the stock with a sell rating, nine have given a hold rating and five have given a buy rating to the stock. The stock presently has an average rating of “Hold” and a consensus target price of $91.82.
In related news, Director Mike S. Zafirovski acquired 2,920 shares of the stock in a transaction dated Thursday, February 23rd. The stock was bought at an average price of $85.67 per share, for a total transaction of $250,156.40. Following the purchase, the director now directly owns 2,920 shares of the company’s stock, valued at approximately $250,156.40. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. Also, Director Robert S. Murley acquired 1,000 shares of the stock in a transaction dated Wednesday, February 1st. The stock was bought at an average price of $76.22 per share, with a total value of $76,220.00. The disclosure for this purchase can be found here. 3.30% of the stock is currently owned by company insiders.
Stericycle, Inc is a business-to-business services provider. The Company focuses on regulated and compliance solutions for healthcare, retail, and commercial businesses. The Company’s segments include Domestic and Canada Regulated Waste and Compliance Services (RCS), Domestic Communication and Related Services (CRS), International RCS and All other.
Want to see what other hedge funds are holding SRCL? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Stericycle Inc (NASDAQ:SRCL).
Receive News & Ratings for Stericycle Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Stericycle Inc and related companies with our FREE daily email newsletter.